141 related articles for article (PubMed ID: 32764701)
1. Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study.
Salo SAS; Lantto E; Robinson E; Myllärniemi M; Laaksonen S; Salo JA; Rantanen T; Ilonen I
Sci Rep; 2020 Aug; 10(1):13257. PubMed ID: 32764701
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of malignant peritoneal mesothelioma: A population-based study.
Salo SAS; Ilonen I; Laaksonen S; Myllärniemi M; Salo JA; Rantanen T
Cancer Epidemiol; 2017 Dec; 51():81-86. PubMed ID: 29080447
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of new TNM staging and serum CA125 in malignant peritoneal mesothelioma].
Wei F; Zheng GQ; Song H; Liang YF; Yin WJ; Sun NN; Yang YX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 May; 38(5):321-326. PubMed ID: 32536066
[No Abstract] [Full Text] [Related]
4. The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.
Carlson B; Harmath C; Turaga K; Kindler HL; Armato SG; Straus C
Abdom Radiol (NY); 2022 May; 47(5):1725-1740. PubMed ID: 35257201
[TBL] [Abstract][Full Text] [Related]
5. Malignant Peritoneal Mesothelioma: Treatment Options and Survival.
Salo SAS; Ilonen I; Laaksonen S; Myllärniemi M; Salo JA; Rantanen T
Anticancer Res; 2019 Feb; 39(2):839-845. PubMed ID: 30711965
[TBL] [Abstract][Full Text] [Related]
6. Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival.
Avesani G; Arshad M; Lu H; Fotopoulou C; Cannone F; Melotti R; Aboagye E; Rockall A
Radiol Med; 2020 Aug; 125(8):770-776. PubMed ID: 32239470
[TBL] [Abstract][Full Text] [Related]
7. Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies.
Tan GH; Kwek JW; Hosseini R; Chanyaputhipong J; Tham CK; Soo KC; Teo MC
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):337-43. PubMed ID: 27098828
[TBL] [Abstract][Full Text] [Related]
8. What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative.
Lee RM; Zaidi MY; Gamboa AC; Speegle S; Kimbrough CW; Cloyd JM; Leiting JL; Grotz TE; Lee AJ; Fournier KF; Powers BD; Dineen SP; Baumgartner J; Veerapong J; Clarke CN; Sussman JJ; Patel S; Hendrix RJ; Lambert LA; Vande Walle KA; Abbott DE; LaRocca CJ; Raoof M; Fackche N; Johnston FM; Staley CA; Maithel SK; Russell MC
Clin Colorectal Cancer; 2020 Mar; 19(1):e1-e7. PubMed ID: 31974019
[TBL] [Abstract][Full Text] [Related]
9. IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma.
Hui S; Guo-Qi Z; Xiao-Zhong G; Chun-Rong L; Yu-Fei L; Dong-Liang Y
Hum Pathol; 2018 Nov; 81():138-147. PubMed ID: 30031101
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab for malignant peritoneal mesothelioma.
Tanaka T; Miyamoto Y; Sakai A; Fujimoto N
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257382
[TBL] [Abstract][Full Text] [Related]
11. Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040.
Oddone E; Bollon J; Nava CR; Minelli G; Imbriani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379304
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors of patients with malignant peritoneal mesothelioma.
Yin W; Zheng G; Yang K; Song H; Liang Y
World J Surg Oncol; 2018 Mar; 16(1):44. PubMed ID: 29506546
[TBL] [Abstract][Full Text] [Related]
13. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
[TBL] [Abstract][Full Text] [Related]
14. Localized biphasic malignant mesothelioma presenting as a giant pelvic wall mass: a rare case report and literature review.
Liu Y; Wu J; Zhao Y; Zhang P; Hua Z; Dong W; Lin T; Liu A
BMC Med Imaging; 2020 May; 20(1):48. PubMed ID: 32375654
[TBL] [Abstract][Full Text] [Related]
15. The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma.
Yin W; Zheng G; Su S; Liang Y
Oncol Res Treat; 2019; 42(6):334-341. PubMed ID: 31063993
[TBL] [Abstract][Full Text] [Related]
16. Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery.
Gadelhak B; Tawfik AM; Saleh GA; Batouty NM; Sobh DM; Hamdy O; Refky B
Abdom Radiol (NY); 2019 Jun; 44(6):2254-2261. PubMed ID: 30788559
[TBL] [Abstract][Full Text] [Related]
17. First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
Fujimoto E; Kijima T; Kuribayashi K; Negi Y; Kanemura S; Mikami K; Doi H; Kitajima K; Nakano T
Expert Rev Anticancer Ther; 2017 Sep; 17(9):865-872. PubMed ID: 28594258
[TBL] [Abstract][Full Text] [Related]
18. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
Diaz-Gil D; Fintelmann FJ; Molaei S; Elmi A; Hedgire SS; Harisinghani MG
Abdom Radiol (NY); 2016 Nov; 41(11):2196-2202. PubMed ID: 27338731
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.
Koh JL; Yan TD; Glenn D; Morris DL
Ann Surg Oncol; 2009 Feb; 16(2):327-33. PubMed ID: 19050972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
